secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001104659-22-123235
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 3.03, 5.03, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals effectuates 1-for-10 reverse stock split effective Nov 30, 2022
--------------------------------------------------------------------------------

- Stockholders approved reverse split at ratio of 1-for-10 at Nov 29 annual meeting.
- Effective 4:05 PM ET Nov 30; shares begin trading on split-adjusted basis Dec 1 under symbol PTPI.
- Outstanding shares reduced from 20,708,024 to approx 2,070,803; fractional shares rounded up.
- Proportionate adjustments made to equity awards, warrants, and convertible preferred.
- CUSIP changes to 71678J209; authorized shares unchanged at 150M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465922123235/0001104659-22-123235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465922123235/tm2231618d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-123235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer